Founder and Chief Science Officer of Eos Neuroscience, a company continuing to engineer optogenetic gene therapies for blindness and chronic pain • Worked closely with Second Sight Medical Products to produce the first ever treatment of neurological blindness, a medical device that is now approved by the FDA for the treatment of retinitis pigmentosa • Early hire, Project Manager, and Researcher at VivoMetrics, a medical device startup that developed a wearable ambulatory monitoring system that continuously collected cardiopulmonary data.
B.A. in Psychology for the University of Washington • Ph.D. in Neuroscience from the University of Southern California
Numerous scientific publications and issued patents • Several career awards including the Burroughs Wellcome Fund CASI award.
Describe the most impressive thing you've done.